| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.1B | $0.0B | $0.1B | $-0.0B | $-0.0B | $0.0B |
| EPS (Basic) | $1.59 | $2.45 | $1.86 | $2.20 | $-1.42 | $-0.02 | $0.38 |
| EPS (Diluted) | $1.52 | $2.37 | $1.83 | $2.17 | $-1.42 | $-0.02 | $0.38 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $2.9B | $2.6B | $2.3B | $1.9B | $1.6B | $1.5B | $1.4B |
| Current Assets | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.0B | $0.1B | $0.1B | $0.0B | $0.1B |
| Total Liabilities | $2.4B | $2.2B | $1.9B | $1.5B | $1.3B | $1.2B | $0.9B |
| Current Liabilities | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.4B | $0.3B | $0.3B | $0.3B | $0.2B | $0.3B | $0.2B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.3B | $-0.3B | $-0.4B | $-0.2B | $-0.2B | $-0.2B | $-0.0B |
| Capital Expenditures | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.2B | $0.3B | $0.3B | $0.2B | $0.1B | $0.2B | $-0.0B |